AZ
Insider
Anthony P. Zook
Chief Executive OfficerAnthony P. Zook (Chief Executive Officer) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in NeoGenomics, Inc. (NEO). Across 1 priced purchase filing, the average 21-session return was -5.7% from execution and -9.0% from disclosure (delay-adjusted; derived). The largest single filing was $149K of NEO (18,900 sh × $7.88, as filed), executed May 6 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-5.7%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-9.0%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$149K
shares × price, as filed
Last traded
May 6 2025
Filed May 8 2025
Median ADV $44.0M across their filed names
Open performance→Volume by month
Buys $149K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
NEORecent filings
NEOPURCHASE
NeoGenomics, Inc.
View filing →
$149K18,900 sh × $7.88
Exec May 6 2025
Filed May 8 2025 · 5:30 PM ET